| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/05/2002 | EP1210454A1 Antisense modulation of shp-1 expression |
| 06/05/2002 | EP1210453A2 Hdac4 and hdac5 in the regulation of cardiac gene expression |
| 06/05/2002 | EP1210445A2 Recombinant microorganisms |
| 06/05/2002 | EP1210444A2 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
| 06/05/2002 | EP1210438A2 Ehrlichia canis genes and vaccines |
| 06/05/2002 | EP1210435A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 06/05/2002 | EP1210434A2 Mammalian interleukin-12 p40 and interleukin b30. combinations thereof. antibodies. uses in pharmaceutical compositions |
| 06/05/2002 | EP1210433A2 Methods and compositions of a novel serine protease inhibitor |
| 06/05/2002 | EP1210432A2 i IN VIVO /i TREATMENT OF JOINT DISEASE USING INTERLEUKIN-1 RECEPTOR ANTAGONISTS |
| 06/05/2002 | EP1210430A2 Muc-1 derived peptides |
| 06/05/2002 | EP1210429A2 Apoptosis proteins |
| 06/05/2002 | EP1210428A1 Pd-1, a receptor for b7-4, and uses therefor |
| 06/05/2002 | EP1210426A2 Polymorphisms in a klotho gene |
| 06/05/2002 | EP1210425A2 Baff receptor (bcma), an immunoregulatory agent |
| 06/05/2002 | EP1210424A1 Novel b7-4 molecules and uses therefor |
| 06/05/2002 | EP1210422A2 Human abc2 transporter and uses thereof |
| 06/05/2002 | EP1210421A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 06/05/2002 | EP1210419A2 Human transmembrane proteins |
| 06/05/2002 | EP1210418A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/05/2002 | EP1210410A2 Metal binding compounds and their use in cell culture medium compositions |
| 06/05/2002 | EP1210408A2 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 06/05/2002 | EP1210405A2 Cardiomyocytes with enhanced proliferative potential, and methods for preparing and using same |
| 06/05/2002 | EP1210375A1 Recombinant proteins and molecular complexes derived therefrom, analogous to molecules involved in immune responses |
| 06/05/2002 | EP1210370A1 Human tumor necrosis factor receptor tr16 |
| 06/05/2002 | EP1210369A1 Monomeric analogues of human insulin |
| 06/05/2002 | EP1210368A2 Use of semaphorin for modulation of cellular efflux |
| 06/05/2002 | EP1210366A1 Homologs of a pneumococcal protein and fragments for vaccines |
| 06/05/2002 | EP1210365A2 Methods and compositions for restoring antibiotic susceptibility in glycopeptide-resistant enterococcus |
| 06/05/2002 | EP1210362A2 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses |
| 06/05/2002 | EP1210360A1 Compounds useful to mimic peptide beta-strands |
| 06/05/2002 | EP1210327A2 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 06/05/2002 | EP1210130A1 Solid wound healing formulations containing fibronectin |
| 06/05/2002 | EP1210121A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 06/05/2002 | EP1210120A1 Nerve cell growth modulators (amphibodies) |
| 06/05/2002 | EP1210119A1 Pharmaceutical compositions for oral and topical administration |
| 06/05/2002 | EP1210117A2 Compositons for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds |
| 06/05/2002 | EP1210115A1 DOSAGES FOR TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 06/05/2002 | EP1210110A1 Prion protein binding proteins and uses thereof |
| 06/05/2002 | EP1210108A2 Use of leptin in inhibition of endothelial cell proliferation |
| 06/05/2002 | EP1210107A2 Bmp-9 compositions and methods for inducing differentiation of cholinergic neurons |
| 06/05/2002 | EP1210106A2 Methods, compositions and kits for promoting recovery from damage to the central nervous system |
| 06/05/2002 | EP1210105A1 High density lipoprotein against organ dysfunction following haemorrhagic shock |
| 06/05/2002 | EP1210104A1 Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions |
| 06/05/2002 | EP1210103A1 Induced regeneration and repair of damaged neurons and nerve axon myelin |
| 06/05/2002 | EP1210102A2 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/05/2002 | EP1210100A1 Method of treating traumatic brain and spinal cord injuries and other neurogenic conditions using non-steroidal anti-inflammatory drugs and naturally occurring conotoxins |
| 06/05/2002 | EP1210099A1 Methods and compositions useful for modulation of angiogenesis using protein kinase raf and ras |
| 06/05/2002 | EP1210067A2 Modulation of release from dry powder formulations |
| 06/05/2002 | EP1210063A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 06/05/2002 | EP1210046A1 Enhanced wound coverage to enhance wound healing |
| 06/05/2002 | EP1124593B1 Method for preparing bone material |
| 06/05/2002 | EP1121144B1 Stable concentrated insulin preparations for pulmonary delivery |
| 06/05/2002 | EP1117420B1 Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues |
| 06/05/2002 | EP1109573B1 PHARMACEUTICAL COMPOSITIONS COMPRISING FACTOR XIIIa FOR NERVE HEALING |
| 06/05/2002 | EP1071442A4 Methods and compositions for peptide synthesis |
| 06/05/2002 | EP1061945B1 Use of vip analogues for preventing and treating brain damage in human babies |
| 06/05/2002 | EP1037658B1 Ifnar/ifn complex |
| 06/05/2002 | EP0968008B1 A stabilized mixture comprising fibrinogen |
| 06/05/2002 | EP0951474B1 Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them |
| 06/05/2002 | EP0951473B1 Cyclosporin derivative, its preparation and pharmaceutical compositions containing same |
| 06/05/2002 | EP0948527B1 Cyclosporin derivatives, their preparation and pharmaceutical compositions containing them |
| 06/05/2002 | EP0925308B1 Compositions and methods for treating infections using analogues of indolicidin |
| 06/05/2002 | EP0904096A4 Cyclic polypeptides comprising a thioether linkage and methods for their preparation |
| 06/05/2002 | EP0871443B1 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 06/05/2002 | EP0815134B1 Modulators of amyloid aggregation |
| 06/05/2002 | EP0813420B1 Treatment of cerebral ischemia and cerebral damage with neuroprotective agent |
| 06/05/2002 | EP0804584B1 Sequences of hepatitis c virus genotype 7 and their use as prophylactic, therapeutic and diagnostic agents |
| 06/05/2002 | EP0804228B1 Medicament containing protein C activation peptide |
| 06/05/2002 | EP0804227B1 Use of lysozyme dimer for treating cancer |
| 06/05/2002 | EP0804182B1 Use of gabapentin in the treatment of anxiety and panic |
| 06/05/2002 | EP0789580B1 Novel cyclosporine preparation forms for oral administration of simple composition and high bio-availability, and process for producing them |
| 06/05/2002 | EP0788501B1 Protein kinase inhibitors for treatment of neurological disorders |
| 06/05/2002 | EP0752866B1 Medicaments for treating restenosis, comprising nitric oxide releasing polymers |
| 06/05/2002 | EP0736095B1 Human circulating cytokine cc-1 |
| 06/05/2002 | EP0724637B2 Corticotropin-releasing factor 2 receptors |
| 06/05/2002 | EP0700299B1 Oxygen-reduced aqueous solution of factor viii |
| 06/05/2002 | EP0663951B1 Chitosan matrices for encapsulated cells |
| 06/05/2002 | EP0658204B1 DNA ENCODING THE HEME-REGULATED EUKARYOTIC INITIATION FACTOR 2$g(a) KINASE |
| 06/05/2002 | CN1352694A Novel system for regulating transgene expression |
| 06/05/2002 | CN1352691A Human complement C3-degrading polypeptide from i(streptococcus pneumoniae) |
| 06/05/2002 | CN1352687A A variant of c6 beta-chemokine leukotactin-1 (shLKn-1) with enhanced biological activity |
| 06/05/2002 | CN1352686A Cytokine receptor chain |
| 06/05/2002 | CN1352684A Vascular endothelial cell growth factor variants and use thereof |
| 06/05/2002 | CN1352683A Compositions and methods for the treatment and diagnosis of breast cancer |
| 06/05/2002 | CN1352651A Method for inhibiting macrophage infiltration using monoconal anti-alpha-D-antibodies |
| 06/05/2002 | CN1352649A Peptides from the TT virus sequence and monospecific antibodies binding to the TT virus |
| 06/05/2002 | CN1352568A Water soluble compositions for bioactive lipophilic compounds |
| 06/05/2002 | CN1352567A A means for the prophylactic and therapeutic treamtent of streptococcal infections |
| 06/05/2002 | CN1352566A Gonadotrophins |
| 06/05/2002 | CN1352565A Agent for treating visual cell function disorder |
| 06/05/2002 | CN1352562A Copper agonist that binds on the copper binding site of APP and/or exerts an inhibiting effect on the release of anyloid A beta peptide |
| 06/05/2002 | CN1352561A Method for enhancing the efficacy of anti-tumor agents |
| 06/05/2002 | CN1352559A Endoparasiticidal combination |
| 06/05/2002 | CN1352528A Milk protein hydrolysate for addressing a bone or dental disorder |
| 06/05/2002 | CN1352523A MSH 5 ablated mice and usest therefor |
| 06/05/2002 | CN1352391A Novel anti-tumor medicine and its screening method and use |
| 06/05/2002 | CN1352305A New polypeptide-human carbamylaspartic dehydrase 10.67 polynucleotide for encoding such polypeptide |
| 06/05/2002 | CN1352304A New polypeptide-carbamylaspartic dehydrase 14.74 and polynucleotide for encoding such polypeptide |
| 06/05/2002 | CN1352303A New polypeptide-human carbamylaspartic dehydrase 9.46 and polynucleotide for encoding such polypeptide |
| 06/05/2002 | CN1352302A New polypeptide-carbamylaspartic dehydrase 9.68 and polynucleotide for encoding such polypeptide |